BrainTale
PrivateLast Round
Series A
Jun 20, 2023
Total Funding Raised
$6.17M
Company Overview
BrainTale operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was a Series A round in June 2023.
BrainTale is a medtech company that provides a software-as-a-service (SaaS) platform using AI to analyze MRI scans of the brain's white matter for the diagnosis, monitoring, and prognosis of neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Healthcare Analytics, Medical Devices
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BrainTale Comparables
Compare BrainTale with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Quibim | 84% | |
| Gleamer | 81% | |
| Brainreader | 80% |
For institutional investors. Book with your work email.
BrainTale Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 20, 2023 | ||||
| Seed | Nov 9, 2020 | ||||
| Grant | Jul 9, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BrainTale Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Paris Business Angels | Seed |
| EIT Health | Grant |
| Arts et Métiers Business Angels | Seed |
| Angels Santé | Seed |
| Femmes Business Angels | Seed |
| Capital Grand Est | Series A |
| Bpifrance | Series A, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 9, 2019
$56K grant received from EIT Health.
For institutional investors. Book with your work email.
BrainTale Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BrainTale's valuation, stock price, and market status.
Is BrainTale a public or private company?
BrainTale is a private company.
What is the current stock price of BrainTale?
BrainTale is a private company, so its shares have no public market price. Caplight tracks BrainTale's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BrainTale worth (valuation)?
Valuation information for BrainTale is not publicly available.
Can I buy BrainTale stock?
BrainTale shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BrainTale's last funding round?
BrainTale's most recent funding round was Series A on June 20, 2023.
Who are the main investors in BrainTale?
Key investors in BrainTale include Angels Santé, Capital Grand Est, MACSF.
Will BrainTale IPO soon?
No public IPO plans have been announced for BrainTale.
How can I track BrainTale secondary market activity?
Caplight tracks bids, offers, and trades in BrainTale's shares on secondary markets.